G Model
PRBI-10418; No. of Pages8
ARTICLE IN PRESS
F.-M. Guo et al. / Process Biochemistry xxx (2015) xxx–xxx
2
6
× His-tagged fusion protein, but the steps were cumbersome and
2.3. Plasmid construction
the yield was unsatisfactory [8].
In this study, we cloned an amidase gene from K. oxytoca KCTC
Ami1 was digested with EcoRI and HindIII, and Ami2 was
digested with NdeI and EcoRI. Subsequently, the digested DNA
fragments were inserted into the same restriction sites of the pET-
30a(+) expression vector under the control of the T7 promoter.
Ligations were performed according to the manufacturer’s proto-
col (Novagen). The constructed recombinant plasmids were named
pET-Ami1 and pET-Ami2.
1
686 [29] and studied how to achieve efficient expression in E. coli.
First, the amidase (KamH) was expressed as a fusion protein with a
kDa peptide containing a 6 × His-tag and an enterokinase cleav-
6
age site at its N-terminus; approximately half of the recombinant
protein was expressed in soluble form, but it had no amidase activ-
ity. Previous studies have indicated that extra amino acid residues
at the terminus of overexpressed proteins can have a profound
effect on the folding and solubility of these proteins [30–34]. There-
fore, we used enterokinase to remove the extra amino acid residues
from the fusion protein and found that the activity was partly
restored. When KamH was expressed in its native form, almost
no inclusion bodies were formed, and the recombinant protein
had maximum activity. Similar results were achieved with het-
erologous expression of other amidases containing an N-terminus
2.4. Expression of KamH in E. coli
Transformation of E. coli BL21(DE3) with pET-Ami1 and pET-
Ami2 was carried out essentially as recommended by Novagen.
Transformed E. coli BL21(DE3) cells were cultivated in LB medium
supplemented with 50 g/ml kanamycin. Cells were incubated
◦
at 37 C on a gyratory shaker until the OD6 reached 1.0. Then,
00
␣
-helical domain. Therefore, amidases of this type may be func-
isopropyl--d-thiogalactopyranoside (IPTG) was added to a final
tionally expressed in their native form, and this strategy may be
an alternative method for the efficient expression of amidases.
Finally, characterization of KamH indicated that this enzyme has
great application potential in the fine chemicals and pharmaceuti-
cal intermediates industries.
concentration of 0.5 mM and the cultures were incubated for 12 h
◦
at 18 C. The cells were harvested by centrifugation (12,000 × g for
10 min), and cell suspensions in 50 mM Tris–HCl buffer (pH 8.0)
were disrupted by sonication (Sonicator 400, Misonix, USA). The
soluble and insoluble fractions were separated by centrifugation
◦
(
12,000 × g for 20 min) at 4 C and analyzed by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) on 12%
polyacrylamide gels with a 4% stacking gel. Gels were stained with
Coomassie Brilliant Blue.
2
. Materials and methods
2.1. Bacterial strains, plasmids, enzymes, and chemical reagents
2.5. Enterokinase cleavage of the extra peptide
The microbial strain K. oxytoca KCTC 1686 was procured from
◦
KCTC (Daejeon, Korea) and was routinely grown at 30 C in lysogeny
broth (LB) medium (1.0% [w/v] bactotryptone, 0.5% [w/v] yeast
extract, 1.0% [w/v] NaCl, pH 7.2). E. coli strains DH5␣ and BL21(DE3)
The recombinant protein produced by E. coli BL21(DE3)/pET-
Ami1 was purified by a combination of Ni-NTA affinity chromatog-
raphy and Superose S10-300 gel filtration chromatography. The
purified protein was dissolved in enterokinase cleavage buffer
(
Novagen, Madison, USA) were used as hosts for plasmid construc-
tion and recombinant amidase production, respectively. Plasmid
pET-30a(+) (Novagen, Madison, USA) was used to construct recom-
binant vectors. The E. coli strains harboring recombinant vector
(50 mM Tris–HCl, pH 8.0, 2 mM CaCl , 0.1% Tween 80, 50 mM NaCl)
2
to yield a protein solution with an apparent protein concentration
of 6.0 mg/ml. A 2-ml aliquot of this enzyme solution was incubated
◦
◦
were routinely cultured at 37 C in LB liquid medium or on LB agar
with 3 U of enterokinase (Stratagene, Shanghai, China) at 35 C
solid medium supplemented with kanamycin (50 g/ml) as appro-
priate. Restriction enzymes (EcoRI, HindIII, NdeI) and T4 DNA ligase
were purchased from Takara, Ltd. (Dalian, China). FastPfu DNA
polymerase and protein markers were purchased from TransGen
Biotech, Ltd. (Beijing, China). All other reagents were commercial
products of analytical grade or higher and were purchased from
standard suppliers.
for 20 h. Then, 100 l of the enterokinase-digested protein was
incubated with 60 l of STI-agarose (Stratagene, Shanghai, China)
and 1 ml of His-tag affinity resin at 4 C for 1 h. The His-tag and
◦
enterokinase were removed by low-speed centrifugation (1000 × g
for 10 min) and the supernatant was used to test enzyme activity.
2.6. Functional expression of other amidases
The microbial strains R. erythropolis MP50 (DSM 9675) and A.
tumefaciens d3 (DSM 9674) were procured from DSMZ (Braun-
schweig, Germany) and were routinely grown in LB medium.
Extraction of genomic DNA was performed as described for KamH.
Amidase nucleotide sequence data from R. erythropolis MP50
2
.2. Genomic DNA extraction and amidase gene subcloning
K. oxytoca KCTC 1686 was cultured in LB liquid medium
◦
at 30 C and cells were harvested from the culture medium
in the late log phase. Genomic DNA (GenBank accession No.
CP003218.1) was extracted using
Kit (Axygen, Hangzhou, China) according to the manufacturer’s
instructions.
Genomic DNA of K. oxytoca KCTC 1686 was used as template to
amplify the amidase gene by polymerase chain reaction (PCR). Two
sets of primers were designed to amplify the gene: primers A1 (for-
ward) and A2 (reverse), with EcoRI and HindIII sites, respectively,
and primers A3 (forward) and A4 (reverse), with NdeI and EcoRI
sites, respectively. The primer sequences and restriction sites are
listed in Table 1. The PCR program was carried out as follows: 1
(MamH) and A. tumefaciens d3 (DamH) appear in the GenBank
a Genomic DNA Isolation
nucleotide sequence database under the number AY026386 and
AF315580. The primer sequences (A5–A12) used to amplify the
amidase genes from these two strains and the restriction sites are
listed in Table 1. The PCR, recombinant plasmid construction, trans-
formation, and expression of recombinant amidases were carried
out as described for KamH.
2.7. Amidase activity assays and determination of protein
concentration
◦
◦
◦
cycle at 94 C for 5 min; 30 cycles of 94 C for 20 s, 57 C for 20 s,
Amidase activity was determined in reaction mixtures (1.0 ml)
consisting of Tris–HCl buffer (50 mM, pH 8.0), 10 mM benzamide,
and an appropriate amount of enzyme. After a 5-min preincuba-
◦
◦
and 72 C for 90 s; and a final extension at 72 C for 10 min. The PCR
◦
tion at 35 C with shaking, the reaction was started by addition
Please cite this article in press as: Guo F-M, et al. Soluble and functional expression of a recombinant enantioselective
amidase from Klebsiella oxytoca KCTC 1686 in Escherichia coli and its biochemical characterization. Process Biochem (2015),